人群抗菌药物消耗与淋球菌耐药性的生态学关联:24个欧洲国家分析
该生态学研究利用欧洲淋球菌抗菌药物监测计划24国的药敏数据与IQVIA MIDAS数据库的抗菌药物消耗数据,构建混合效应线性/逻辑回归模型,分析2009–2015年国家层面头孢菌素、氟喹诺酮类和大环内酯类消耗与滞后1年的淋球菌最低抑菌浓度(MIC)及耐药率的关系。结果显示头孢菌素消耗与头孢曲松和头孢克肟几何平均MIC呈正相关(两者P<.05),氟喹诺酮类消耗与环丙沙星耐药率呈正相关(P<.05)。结论提示特定抗菌药物的人群消耗差异可能促成不同地区淋球菌耐药水平差异,需进一步干预高消耗人群和核心群体的抗菌药物误用和过度使用。
要点
- 头孢菌素消耗与淋球菌对头孢曲松和头孢克肟的几何平均MIC正相关(P<.05)。
- 氟喹诺酮类消耗与淋球菌对环丙沙星耐药率正相关(P<.05)。
- 人群抗菌药物消耗差异可能解释不同地区淋球菌耐药水平差异。
核心结论
- 特定抗菌药物的人群消耗差异可能促成不同地区淋球菌耐药水平差异,需干预高消耗人群和核心群体的抗菌药物误用与过度使用。
研究设计与样本
- 生态学分析,使用欧洲淋球菌抗菌药物监测计划24国药敏数据和IQVIA MIDAS数据库抗菌药物消耗数据,构建混合效应线性/逻辑回归模型。
主要发现
- 头孢菌素消耗与头孢曲松和头孢克肟几何平均MIC呈正相关(P<.05)。
- 氟喹诺酮类消耗与环丙沙星耐药率呈正相关(P<.05)。
关键数值与推荐
- 解释变量为国家层面头孢菌素、氟喹诺酮类和大环内酯类消耗(标准剂量/1000人/年,2009–2015年)。
- 结局变量为滞后1年的头孢曲松、头孢克肟、阿奇霉素和环丙沙星几何平均MIC(2010–2016年)。
- 头孢菌素消耗与头孢曲松和头孢克肟几何平均MIC正相关,两者P<.05。
- 氟喹诺酮类消耗与环丙沙星耐药率正相关,P<.05。
临床怎么用
- 在高消耗人群和核心群体中减少抗菌药物误用与过度使用,可能有助于控制淋球菌耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There are substantial variations between different populations in the susceptibility of Neisseria gonorrhoeae to antimicrobials, and the reasons for this are largely unexplored. We aimed to assess whether the population-level consumption of antimicrobials is a contributory factor. METHODS: Using antimicrobial susceptibility data from 24 countries in the European Gonococcal Antimicrobial Surveillance Programme and antimicrobial consumption data from the IQVIA MIDAS database, we built mixed-effects linear/logistic regression models with country-level cephalosporin, fluoroquinolone, and macrolide consumption (standard doses/1000 population/year) as the explanatory variables (from 2009 to 2015) and 1-year-lagged ceftriaxone, cefixime, azithromycin, and ciprofloxacin geometric mean minimum inhibitory concentrations (MICs) as the outcome variables (from 2010 to 2016). RESULTS: Positive correlations were found between the consumption of cephalosporins and the geometric mean MICs of ceftriaxone and cefixime (P < .05 for both comparisons). Fluoroquinolone consumption was positively associated with the prevalence of resistance to ciprofloxacin (P < .05). CONCLUSIONS: Differences in the population-level consumption of particular antimicrobials may contribute to variations in the level of antimicrobial resistance in N. gonorrhoeae in different settings. Further interventions to reduce misuse and overuse of antimicrobials in high-consumption populations and core groups are required.
引用
- Kenyon C, Buyze J, Spiteri G, et al. Population-Level Antimicrobial Consumption Is Associated With Decreased Antimicrobial Susceptibility in Neisseria gonorrhoeae in 24 European Countries: An Ecological Analysis. J Infect Dis. 2020. PMID: 30957153. doi:10.1093/infdis/jiz153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。